Berkeley, California-based Eko Devices has received FDA clearance for Duo, a smart heart monitor that is a combination of a digital stethoscope and portable electrocardiogram. Duo is intended as a ...

Cardiovascular and pulmonary diseases are among the leading causes of death worldwide, with millions of patients unaware of their risk factors, often due to limited access to effective detection tools ...

Eko Health, which has developed digital stethoscopes that use AI to detect different heart conditions, received clearance for an algorithm that can spot when hearts are pumping less than they should.

Smart stethoscope company Eko uses AI to help providers identify early signs of cardiovascular disease: it has devices that can be used by both clinicians and patients at home to listen to heart and ...

SAN FRANCISCO, Jan. 29, 2026 /PRNewswire/ -- Eko Health, a leader in AI-powered cardiac and pulmonary disease detection, today announced the publication of the TRICORDER (Triple Cardiovascular Disease ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More True story: When I was 15, I went in for a sports physical and the ...

Heart disease remains the leading cause of death in the U.S. and around the world, but rapid, early screening options are still few and far between. Digital stethoscope developer Eko hopes to change ...

Eko’s smart stethoscopes have been used by U.S. physicians to automatically detect signs of atrial fibrillation and heart murmurs since its first FDA clearance arrived in 2020. A new regulatory OK ...

Eko—a maker of smart stethoscopes paired with software—announced Tuesday the launch of its newly redesigned app for cardiovascular disease screening. The Oakland, California company is focused on ...

SANTA MONICA, Calif. & EMERYVILLE, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the direct-to-consumer healthcare apparel and lifestyle brand, and Eko Health, Inc. (“Eko”), a leading innovator in ...